GB2304340A - (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor - Google Patents

(-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Info

Publication number
GB2304340A
GB2304340A GB9627127A GB9627127A GB2304340A GB 2304340 A GB2304340 A GB 2304340A GB 9627127 A GB9627127 A GB 9627127A GB 9627127 A GB9627127 A GB 9627127A GB 2304340 A GB2304340 A GB 2304340A
Authority
GB
United Kingdom
Prior art keywords
pyridyl
methyl
butyric acid
phenoxy
cellular adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9627127A
Other versions
GB2304340B (en
GB9627127D0 (en
Inventor
Stuart Dennett Mills
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of GB9627127D0 publication Critical patent/GB9627127D0/en
Publication of GB2304340A publication Critical patent/GB2304340A/en
Application granted granted Critical
Publication of GB2304340B publication Critical patent/GB2304340B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

The novel optically active compound (-)-(3R)-3-methyl-4--4-[4-(4-pyridyl)-piperazine-1-yl]phenoxy butyric acid, and pharmaceutically-acceptable salts, esters, amides or solvates thereof. Processes for the preparation of the compound, pharmaceutical compositions containing the compound and its use to inhibit cellular adhesion, for example platelet aggregation.
GB9627127A 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor Expired - Fee Related GB2304340B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
PCT/GB1996/001260 WO1996038416A1 (en) 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Publications (3)

Publication Number Publication Date
GB9627127D0 GB9627127D0 (en) 1997-02-19
GB2304340A true GB2304340A (en) 1997-03-19
GB2304340B GB2304340B (en) 1998-07-29

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9627127A Expired - Fee Related GB2304340B (en) 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Country Status (31)

Country Link
EP (1) EP0796247A1 (en)
JP (1) JP2885941B2 (en)
KR (1) KR100245957B1 (en)
AT (1) AT406675B (en)
AU (1) AU710105B2 (en)
BE (1) BE1009520A5 (en)
BR (1) BR9606409A (en)
CA (1) CA2194397A1 (en)
CH (1) CH691808A5 (en)
CZ (1) CZ26997A3 (en)
DE (1) DE19680509T1 (en)
DK (1) DK10697A (en)
ES (1) ES2137886B1 (en)
FI (1) FI970393A (en)
GB (1) GB2304340B (en)
GR (1) GR1002702B (en)
HU (1) HUP9700274A3 (en)
IE (1) IE960405A1 (en)
IL (1) IL118477A0 (en)
IT (1) IT1290839B1 (en)
LU (1) LU90008B1 (en)
MC (1) MC2418A1 (en)
MX (1) MX9700379A (en)
NL (1) NL1003243C2 (en)
NO (1) NO307460B1 (en)
NZ (1) NZ308597A (en)
PL (1) PL318440A1 (en)
SE (1) SE510812C2 (en)
SK (1) SK13097A3 (en)
TR (1) TR199700020T1 (en)
WO (1) WO1996038416A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022834A1 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic derivatives as platelet aggregation inhibitors
WO1994022835A2 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022834A1 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic derivatives as platelet aggregation inhibitors
WO1994022835A2 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors

Also Published As

Publication number Publication date
NO307460B1 (en) 2000-04-10
SK13097A3 (en) 1997-08-06
AU710105B2 (en) 1999-09-16
SE9700203D0 (en) 1997-01-24
IT1290839B1 (en) 1998-12-14
JPH09512836A (en) 1997-12-22
PL318440A1 (en) 1997-06-09
CA2194397A1 (en) 1996-12-05
NO970437L (en) 1997-02-20
GB2304340B (en) 1998-07-29
NO970437D0 (en) 1997-01-31
AT406675B (en) 2000-07-25
NZ308597A (en) 1998-11-25
ES2137886A1 (en) 1999-12-16
JP2885941B2 (en) 1999-04-26
ITMI961113A0 (en) 1996-05-31
EP0796247A1 (en) 1997-09-24
HUP9700274A3 (en) 2000-02-28
ES2137886B1 (en) 2000-08-16
ATA900596A (en) 1999-12-15
HU9700274D0 (en) 1997-04-28
NL1003243C2 (en) 1996-12-04
GB9627127D0 (en) 1997-02-19
FI970393A0 (en) 1997-01-30
GR1002702B (en) 1997-05-22
ITMI961113A1 (en) 1997-12-01
TR199700020T1 (en) 1997-04-22
DK10697A (en) 1997-04-01
BR9606409A (en) 1997-09-30
SE510812C2 (en) 1999-06-28
LU90008B1 (en) 1997-04-16
SE9700203L (en) 1997-01-24
IL118477A0 (en) 1996-09-12
WO1996038416A1 (en) 1996-12-05
FI970393A (en) 1997-01-30
AU5827296A (en) 1996-12-18
CH691808A5 (en) 2001-10-31
CZ26997A3 (en) 1997-08-13
KR100245957B1 (en) 2000-04-01
IE960405A1 (en) 1996-12-11
HUP9700274A2 (en) 1999-06-28
BE1009520A5 (en) 1997-04-01
DE19680509T1 (en) 1997-12-04
MX9700379A (en) 1997-04-30
KR970704689A (en) 1997-09-06
MC2418A1 (en) 1997-05-23

Similar Documents

Publication Publication Date Title
NO923948L (en) THIOFENSULPHONAMIDES WHICH CAN BE USED AS CARBONIC ACID ANHYDRASE INHIBITORS
DK0705254T3 (en) Phenyl heterocyclic compounds as cyclooxygenase-2 inhibitors
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
MY114388A (en) Multiple unit pharmaceutical preparation
ES8609251A1 (en) N-Aryl-N-(4-Piperidinyl)amides and pharmaceutical compositions and methods employing such compounds.
FI956341A (en) Methylphosphonic acid ester, process for its preparation and its use
FI915093A0 (en) SACKARINDERIVAT ANVAENDBARA SOM INHIBITORER FOER PROTEOLYTISKT ENZYM OCH DERAS FRAMSTAELLNING.
BR0009244A (en) Diheter metalloprotease inhibitors replaced
NO912888D0 (en) PROCEDURE FOR THE PREPARATION OF NEW PEPERIDYLETHERS AND THIOETHERS.
AU545292B2 (en) Substituted 3-amino-sydnoneimines
GB2304340A (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor
IL112630A (en) Derivatives of (2-(ar)alkyldithioindane-2-carboxamido) tricyclic-oxobenzazepine and similar compouds useful as inhibitors of enkephalinase, their preparation and pharmaceutical compositions containing them
NO170974C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC USE (((((3-PYRIDINYL) METHYLE) AMINO) OXYY) ALKANIC ACIDS AND ESTERS THEREOF AND THE INTERMEDIATE PRODUCT FOR USE IN THE PROCEDURE
AU6599186A (en) N-(6-(4-0-hydrxyphenyl-1,3-dioxan-cis-5-yl)hexenoyl) suphonamide derivatives
ES8403855A1 (en) 1-(2,4-Dichlorophenoxy)-3-(3,4-dimethoxy-beta-phenethylamino)-propan-2-0l, processes for its preparation and pharmaceutical compositions containing it.
WO1991018600A1 (en) Pharmaceutical compositions for the treatment of ventricular fibrillation, impending myocardia infarction syndrome and angina containing n-(benzoyl-3 phenyl) (pyridyl-3)-3 1h,3h-pyrrolo[1,2-c] thiazolecarboxamide-7

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee